News

EP PerMed - Fast Track Validation Programme 2026 for start-ups & small teams of researchers

Published on | 13 hours ago

Programmes Health

The Fast Track Programme of the European Partnership for Personalised Medicine (EP PerMed) offers support to start-ups and small teams and researchers at a pivotal stage of development, ensuring that promising personalised medicine (PM) innovations do not stall due to lack of validation resources and guidance.

The Fast Track Programme offers targeted support to accelerate the validation and adoption of innovative PM solutions. The programme helps early-stage innovators progress by at least one Technology Readiness Level through dedicated validation studies carried out together with specialised European validation centres. 

More information, including the call text and details how to apply & evaluation process are available here. The deadline to submit your application is 10 March 2026. An information webinar on the Fast Track call will take place on 20 January and a final Q&A session on 3 March. 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

1779 articles available search in articles 

Testimonial

BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment

The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.